Form 4: Zimmer Biomet Director Farrell Reports Phantom Stock Unit Acquisition

Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under deferred compensation plan.

Summary

• Michael J. Farrell, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of 288.863 phantom stock units on March 31, 2025.
• These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price is 1-for-1, and the units will be settled in cash within sixty days after Farrell's service as a director ends.
• Following the transaction, Farrell beneficially owns 15,580.5 phantom stock units, including 32.604 units accrued on January 31, 2025, through dividend reinvestment.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral to positive as it aligns director interests with company performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan allows for tax-advantaged savings for non-employee directors.

Future Outlook

The phantom stock units will be settled in cash within sixty days after Farrell's service as a director ends.

Industry Context

This filing is a routine disclosure related to director compensation and is common in publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Deferred compensation plans for non-employee directors are a common practice among publicly traded companies, including Zimmer Biomet's competitors such as Stryker Corporation (SYK) and Johnson & Johnson (JNJ).
• These plans often involve phantom stock units or similar instruments that provide directors with a stake in the company's future performance without granting actual shares until a later date.
• The specific terms of these plans, such as vesting schedules and settlement methods, can vary widely among companies.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates

Keywords

Zimmer Biomet, Director, Phantom Stock Units, Deferred Compensation, Form 4, ZBH, Beneficial Ownership